Submit RFP

November 2023

Beyond Unit Cost: Evaluating Clinical Programs and Capabilities of PBMs

Uncategorized /

Read the full article by AlignRx COO Greg Sanderson on Employee Benefit News.  Drug pricing is typically the main factor brokers and employer groups consider when evaluating PBMs. It makes sense. In a highly complex marketplace, their primary focus is getting their members’ prescriptions filled for the lowest price.   But projecting – and ultimately lowering […]

Beyond Unit Cost: Evaluating Clinical Programs and Capabilities of PBMs Read More »

Medicaid AMP Cap Removal: Market Changes & Rx Strategies Amidst New Provisions

Clinical Insights, Pharmacy Benefit Management /

The ever-evolving pharmaceutical landscape is no stranger to reforms and regulations. With the recent changes brought about by the American Rescue Plan (ARP) of 2021, both Pharmacy Benefit Managers (PBMs) and Drug Manufacturers are adjusting their strategies. This article dives deep into these shifts and the subsequent reactions from industry stakeholders.   Market Events and their

Medicaid AMP Cap Removal: Market Changes & Rx Strategies Amidst New Provisions Read More »

Aligned for better outcomes
© 2024 AlignRx All Rights Reserved
Privacy Policy
Terms of Use
Aligned for better outcomes | © 2024 AlignRx All Rights Reserved | Privacy Policy | Terms of Use
CloseMenu
CloseMenu

Featured Content

Employer Group Saves $1.8M on Specialty Drug Costs
Read more
AlignRx has invested heavily in bringing together the best minds in the business.
Read more